antiantibody
onartuzumab
lymphoproliferative
talizumab
lucatumumab
antilymphangiogenic
leucocrit
afutuzumab
lymphographic
lymphodeplete
dorlixizumab
lymphocytolytic
cyclophosphamide
nofetumomab
lymphangial
lymphogram
teplizumab
amivantamab
hematogone
patritumab
edrecolomab
amatuximab
milatuzumab
panitumumab
lymphadenia
-lim-
lymphomatogenesis
lymphoepithelium
tenatumomab
lymphoplasmacytoid
lymphocytic
zalutumumab
MALToma
MALT lymphoma
angioimmunoblastic
lymphangiographically
loncastuximab tesirine
lymphocytopoietic
lymphopenic
drozitumab
monoantibody
-mab
diffuse large B-cell lymphoma
intralymphocytic
inotuzumab ozogamicin
lymphosufficient
defense mechanism
ensituximab
lymphoplasmacellular
Waldenström's macroglobulinemia